⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| B-D-Galactose SCHEMBL6676095 | 0.74 | LGALS3 (0.39) | — | |
| SCHEMBL2534218 | 0.72 | — | — | |
| SCHEMBL9008696 | 0.71 | — | — | |
| SCHEMBL13823418 | 0.71 | — | — | |
| SCHEMBL3917765 | 0.71 | — | — | |
| SCHEMBL9633973 | 0.67 | — | — | |
| SCHEMBL11868209 | 0.66 | — | — | |
| SCHEMBL11746853 | 0.63 | — | — | |
| SCHEMBL16746807 | 0.63 | — | — | |
| SCHEMBL3510173 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12128257-B2 | Extracts of Isochrysis sp | SYMRISE AG (DE) | 2024-10-29 | — | — | US | disclosed |
| US-20240208984-A1 | BIVALENT LIGANDS TO UNDERSTAND DIMERIZATION OF THE MU OPIOID RECEPTOR AND THE CHEMOKINE RECEPTOR CCR5 IN NEUROLOGICAL DISORDERS | VIRGINIA COMMONWEALTH UNIVERSITY | 2024-06-27 | — | — | US | disclosed |
| EP-4313051-A1 | BIVALENT LIGANDS TO UNDERSTAND DIMERIZATION OF THE MU OPIOID RECEPTOR AND THE CHEMOKINE RECEPTOR CCR5 IN NEUROLOGICAL DISORDERS | Virginia Commonwealth University (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022212471-A1 | BIVALENT LIGANDS TO UNDERSTAND DIMERIZATION OF THE MU OPIOID RECEPTOR AND THE CHEMOKINE RECEPTOR CCR5 IN NEUROLOGICAL DISORDERS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2022-10-06 | — | — | WO | disclosed |
| CN-110483488-B | Isopentenyl flavonoid compound and preparation method and application thereof | 河南中医药大学 | 2021-09-21 | — | — | CN | disclosed |
| EP-3840751-A1 | NON-PEPTIDE OPIOID RECEPTOR MODULATORS | Virginia Commonwealth University (US) | 2021-06-30 | — | — | EP | disclosed |
| US-11014933-B2 | Non-peptide opioid receptor modulators | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2021-05-25 | — | — | US | disclosed |
| US-20200216458-A1 | NON-PEPTIDE OPIOID RECEPTOR MODULATORS | VIRGINIA COMMONWEALTH UNIVERSITY | 2020-07-09 | — | — | US | disclosed |
| WO-2020041159-A1 | NON-PEPTIDE OPIOID RECEPTOR MODULATORS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2020-02-27 | — | — | WO | disclosed |
| CN-110483488-A | A kind of isopentene group flavone compound and its preparation method and application | UNIV HENAN CHINESE MEDICINE | 2019-11-22 | — | — | CN | disclosed |
| CN-105473595-A | Carboxylic acid compounds in treatment of diabetes mellitus | FUJIAN HAIXI PHARMACEUTICALS CO LTD | 2016-04-06 | — | — | CN | disclosed |
| US-7795299-B2 | Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2010-09-14 | — | — | US | disclosed |
| US-20090118356-A1 | NEO-TANSHINLACTONE AND ANALOGS AS POTENT AND SELECTIVE ANTI-BREAST CANCER AGENTS | NORTH CAROLINA STATE UNIVERSITY (US) | 2009-05-07 | — | — | US | disclosed |
| EP-1722779-A4 | NEO-TANSHINLACTONE AND ANALOGS AS POTENT AND SELECTIVE ANTI-BREAST CANCER AGENTS | UNIV NORTH CAROLINA (US) | 2009-05-06 | — | — | EP | disclosed |
| US-7495026-B2 | Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2009-02-24 | — | — | US | disclosed |
| CN-101166750-A | Furanopyrimidine compounds and thienopyrimidine compounds for therapy | BIOCRYST PHARM INC (US) | 2008-04-23 | — | — | CN | disclosed |
| US-7307173-B1 | Pyrroline chromophores | UNIVERSITY OF WASHINGTON (US) | 2007-12-11 | — | — | US | disclosed |
| EP-1722779-A1 | NEO-TANSHINLACTONE AND ANALOGS AS POTENT AND SELECTIVE ANTI-BREAST CANCER AGENTS | The University of North Carolina at Chapel Hill (US) | 2006-11-22 | — | — | EP | disclosed |
| US-20050250751-A1 | Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-11-10 | — | — | US | disclosed |
| WO-2005087225-A1 | NEO-TANSHINLACTONE AND ANALOGS AS POTENT AND SELECTIVE ANTI-BREAST CANCER AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-09-22 | — | — | WO | disclosed |